Transarterial medtronic corevalve system implantation for degenerated surgically implanted aortic prostheses

Circulation: Cardiovascular Interventions

Volumn 4, Issue 5, 2011, Pages 488-494

  Descoutures, Fleur ^a   Himbert, Dominique ^a   Radu, Costin ^a   Iung, Bernard ^a   Cueff, Caroline ^a   Messika Zeitoun, David ^a   Ducrocq, Gregory ^a   Brochet, Eric ^a   Nataf, Patrick ^a   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Bioprosthesis; Reoperation; Transcatheter aortic valve implantation; Valve degeneration; Valve in valve

Indexed keywords

ADULT; AGED; ALLOGRAFT; AORTA PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEMODYNAMICS; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; STENT; SURGICAL RISK; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CATHETERIZATION, PERIPHERAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; STROKE;

EID: 82955240680     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.962589     Document Type: Article

References (40)

1. Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007;32:609-661. (Pubitemid 350001365)
2. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137:82-90.
3. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink Al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268. (Pubitemid 46276943)
4. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118: e523-e661.
5. Eitz T, Fritzsche D, Kleikamp G, Zittermann A, Horstkotte D, Korfer R. Reoperation of the aortic valve in octogenarians. Ann Thorac Surg. 2006;82:1385-1390. (Pubitemid 44402337)
6. Jaussaud N, Gariboldi V, Giorgi R, Grisoli D, Chalvignac V, Thuny F, Riberi A, Collart F. Risk of reoperation for aortic bioprosthesis dysfunction. J Heart Valve Dis. 2009;18:256-261.
7. Vogt PR, Brunner-LaRocca H, Sidler P, Zünd G, Truniger K, Lachat M, Turina J, Turina MI. Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg. 2000;17:134-139. (Pubitemid 30145585)
8. Jamieson WR, Burr LH, Miyagishima RT, Janusz MT, Fradet GJ, Ling H, Lichtenstein SV. Re-operation for bioprosthetic aortic structural failure: risk assessment. Eur J Cardiothorac Surg. 2003;24:873-878. (Pubitemid 37476361)
9. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Détaint D, Brochet E, Messika-Zeitoun D, Francis F, Ibrahim H, Nataf P, Vahanian A. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303-311.
10. Al-Attar N, Himbert D, Descoutures F, Iung B, Raffoul R, Messika- Zeitoun D, Brochet E, Francis F, Ibrahim H, Vahanian A, Nataf P. Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg. 2009;87:1757-1762.
11. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
12. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg firstin- man study. Circulation. 2006;114:1616-1624. (Pubitemid 44547432)
13. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57: 253-269.
14. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763. (Pubitemid 47255993)
15. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol. 2009;53:1829-1836.
16. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
17. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214-1223.
18. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current thirdgeneration self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76. (Pubitemid 46970878)
19. Thomas M, Schymik G, Walther T, Himbert D, Lefévre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122: 62-69.
20. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
21. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-197.
22. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
23. Bruschi G, DeMarco F, Oreglia J, Colombo P, Fratto P, Lullo F, Paino R, Martinelli L, Klugmann S. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated aortic bioprosthesis. J Cardiovasc Med (Hagerstown). 2010;11:182-185.
24. Khawaja MZ, Haworth P, Ghuran A, Lee L, de Belder A, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol. 2010;55:97-101.
25. Krumsdorf U, Bekeredjian R, Korosoglou G, Kreuzer J, Rieck BJ, Kallenbach K, Katus HA, Rottbauer W. Images and case reports in interventional cardiology: percutaneous aortic "valve in valve" implantation for severe aortic regurgitation in a degenerated bioprosthesis. Circ Cardiovasc Interv. 2010;3:e6-e7.
26. Napodano M, Cutolo A, Fraccaro C, Tarantini G, Bonato R, Bianco R, Gerosa G, Iliceto S, Ramondo A. Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis. J Thorac Cardiovasc Surg. 2009;138:1027-1028.
27. Olsen LK, Engstrom T, Sondergaard L. Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft. J Invasive Cardiol. 2009;21:E197-E200.
28. Ussia GP, Barbanti M, Tamburino C. Treatment of severe regurgitation of stentless aortic valve prosthesis with a self-expandable biological valve. J Invasive Cardiol. 2009;21:E51-E54.
29. Klaaborg KE, Egeblad H, Jakobsen CJ, Terp K, Lindskov C, Andersen HR, Thuesen L. Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve. Ann Thorac Surg. 2009;87:1943-1946.
30. Kempfert J, Van Linden A, Linke A, Borger MA, Rastan A, Mukherjee C, Ender J, Schuler G, Mohr FW, Walther T. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann Thorac Surg. 2010;89:1934 -1041.
31. Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodés-Cabau J, Osten M, Horlick E, Wendler O, Dumont E, Carere RG, Wijesinghe N, Nietlispach F, Johnson M, Thompson CR, Moss R, Leipsic J, Munt B, Lichtenstein SV, Cheung A. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848 -1857.
32. Seiffert M, Franzen O, Conradi L, Baldus S, Schirmer J, Meinertz T, Reichenspurner H, Treede H. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv. 2010;76:608-615.
33. Walther T, Falk V, Borger MA, Kempfert J, Ender J, Linke A, Schuler G, Mohr FW. Transapical aortic valve implantation in patients requiring redo surgery. Eur J Cardiothorac Surg. 2009;36:231-234.
34. Dainese L, Fusari M, Trabattoni P, Biglioli P. Redo in aortic homograft replacement: transcatheter aortic valve as a valid alternative to surgical replacement. J Thorac Cardiovasc Surg. 2010;139:1656-1657.
35. Ferrari E, Marcucci C, Sulzer C, von Segesser LK. Which available transapical transcatheter valve fits into degenerated aortic bioprostheses? Interact Cardiovasc Thorac Surg. 2010;11:83-85.
36. Kelpis TG, Mezilis NE, Ninios VN, Pitsis AA. Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis. J Thorac Cardiovasc Surg. 2009;138:1018-1020.
37. Maroto LC, Rodriguez JE, Cobiella J, Marcos P. Transapical off-pump aortic valve-in-valve implantation in two elderly patients with a degenerated porcine bioprosthesis. Eur J Cardiothorac Surg. 2010;37: 738-740.
38. Ng AC, van der Kley F, Delgado V, Shanks M, van Bommel RJ, de Weger A, Tavilla G, Holman ER, Schuijf JD, van de Veire NR, Schalij MJ, Bax JJ. Percutaneous valve-in-valve procedure for severe paravalvular regurgitation in aortic bioprosthesis. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:522-523.
39. Rodes-Cabau J, Dumont E, Doyle D, Lemieux J. Transcatheter valvein- valve implantation for the treatment of stentless aortic valve dysfunction. J Thorac Cardiovasc Surg. 2010;140:246-248.
40. Walther T, Kempfert J, Borger MA, Fassl J, Falk V, Blumenstein J, Dehdashtian M, Schuler G, Mohr FW. Human minimally invasive off-pump valve-in-a-valve implantation. Ann Thorac Surg. 2008;85: 1072-1073. (Pubitemid 351260026)